Episode
Serge Saxonov’s Major Stock Sale Explained
- Published
- Jun 1, 2026
- Duration seconds
- 100
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/serge-saxonov-s-major-stock-sale-explained/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/serge-saxonov-s-major-stock-sale-explained.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Serge Saxonov, CEO of 10x Genomics, dumped nearly 29,000 shares in a big move worth $709K — the largest such sale in two years. But don’t panic: half was tax-related, half was from a pre-approved plan to avoid insider trading suspicions. He still owns over a million shares directly and indirectly. The stock surged after the sale, hitting a new yearly high — hinting his move was more about financial planning than losing confidence in the company. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/90e554c39ac0fac8